)
Edge12 Jun 2026
Set in Stone: The Story of Richemont
From a South African tobacco company to Cartier, a deep dive into how Richemont built one of the world's leading hard luxury empires.
BioMarin Pharmaceutical
BioMarin Pharmaceutical (BMRN) investor relations material
BioMarin Pharmaceutical AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary2 Jun, 2026
Opening remarks and agenda
The meeting was called to order by the CEO, who welcomed participants and outlined the virtual format and rules of conduct.
The Secretary confirmed the availability of the stockholder list and notice of meeting, and the Inspector of Election was appointed.
A quorum was established with 90.96% of shares represented, allowing business to proceed.
Board and executive committee updates
Ten directors were nominated for election to serve until the next annual meeting or until successors are elected.
Shareholder proposals
Four proposals were presented: election of directors, ratification of KPMG LLP as auditor, advisory vote on executive compensation, and approval of an amendment to the 2017 Equity Incentive Plan.
2017 Equity Incentive Plan amendment status
Quorum percentage for the 2026 annual meeting
Ratification of the independent auditor for 2026
Status of the 2017 Equity Incentive Plan update
Percentage of shares represented at the meeting
Outcome of the advisory vote on executive pay
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from BioMarin Pharmaceutical
- Q1 2026 revenue up 3% to $766.2M; Amicus deal boosts 2026 outlook but net income drops.BMRN
Q1 202610 May 2026 - Proxy covers director elections, equity plan amendment, strong 2025 results, and ESG progress.BMRNProxy filing22 Apr 2026
- Key votes include director elections, auditor ratification, and executive pay approval.BMRNProxy filing21 Apr 2026
- FY'25 revenue hits $3.2B; Amicus deal and pipeline catalysts drive double-digit growth.BMRN44th Annual J.P. Morgan Healthcare Conference8 Apr 2026
- Strong 2025 growth, major 2026 clinical milestones, and Amicus acquisition drive future outlook.BMRNBarclays 28th Annual Global Healthcare Conference11 Mar 2026
- Strong 2025 growth, major pipeline milestones, and Amicus acquisition set to drive future value.BMRNLeerink Global Healthcare Conference 20269 Mar 2026
- 2026 guidance projects solid growth amid competition, with pipeline and acquisitions fueling long-term value.BMRNTD Cowen 46th Annual Health Care Conference4 Mar 2026
- 2025 revenue up 13% with strong VOXZOGO and enzyme therapies growth; Amicus deal to boost future gains.BMRNQ4 202523 Feb 2026
- Q2 revenue up 20% to $712M, guidance raised, and $495M debt repaid as VOXZOGO demand surges.BMRNQ2 20242 Feb 2026
Next BioMarin Pharmaceutical earnings date
Q2 20263 Aug, 2026
BioMarin Pharmaceutical
Next BioMarin Pharmaceutical earnings date
Q2 20263 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage